selinexor and Leukemia-Lymphoma--Adult-T-Cell

selinexor has been researched along with Leukemia-Lymphoma--Adult-T-Cell* in 1 studies

Other Studies

1 other study(ies) available for selinexor and Leukemia-Lymphoma--Adult-T-Cell

ArticleYear
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.
    Blood cancer journal, 2021, 02-01, Volume: 11, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Leukemia-Lymphoma, Adult T-Cell; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Suppressor Protein p53

2021